Atezolizumab联合EP方案在广泛期小细胞肺癌的一线治疗中获批

FDA Approves Atezolizumab in Combination with Chemotherapy for The Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer

评论文献:Horn L,Mansfield AS,Szczesna A,et al. First-line Atezolizumab plus chemotherapy inextensive-stage small-cell lung cancer[J]. N Engl JMed,2018,379(23):2220-2229.IMpower133作为TOP5的重磅研究在2018年世界肺癌大会上公布结果,文章同步发表于《N Engl JMed》上,这是小细胞肺癌(small cell lung cancer,SCLC)近20年来一线治疗方案首次获得突破。